cdk4 glutathione Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancer Cyclin D-Cdk4,6 drives cell cycle
Cyclin D Cdk4,6 drives cell cycle progression via the retinoblastoma protein's C terminal helix bioRxiv Diet metabolism transcription axis modulates the sensitivity to CDK4 6 inhibitors through RB1 in prostate cancer: Cell Reports Cyclin D Cdk4,6 Drives Cell Cycle Progression via the Retinoblastoma Protein's C Terminal Helix PMC CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis Competent Conformations, Offering Drug Targets JACS Au Cyclin D CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation Circulation Research Breaking Cancer's Momentum: CDK4 6 Inhibitors and the Promise of Combination Therapy
Pay in 4 interest-free payments of $7.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12





